Join our newsletter. Sign up today

Company

Who we are

Lunaphore is a Swiss firm born with the vision of bringing –omics like approaches to in-situ tissue analytics for cancer research and diagnostic purposes.

Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results much faster than current techniques and aiming to automate some of the most sophisticated assays thanks to high-precision fluidics. We further enable digital pathology through the integration of imaging systems such as a microscope with sequential data extraction. Lunaphore has been repeatedly recognized for its innovation.

LALATechnology

Technology

Lunaphore has developed a unique microfluidic technology called Fast Fluidic Exchange Technology (FFeX) which lies at the core of our innovation.

Learn more about FFeX

Investors

We are looking forward to meeting visionary investors who wish to shape with us the future of cancer research. Send us an e-mail to [email protected]

Hi! We use cookies to improve this website. By continuing to use our services, you are giving us your consent to use cookies. Learn more about our privacy policy and our terms of use.
I agree